Martin Shkreli, a 32-year-old pharmaceutical executive who infamously
raised the price of a life-saving AIDs and cancer drug from $13.50 a pill to $750 a pill, is the proud owner of the
Wu-Tang Clan’s one-of-a-kind album. A lengthy piece in
Bloomberg Business about the sale of the LP,
Once Upon a Time in Shaolin, revealed the identity of the mystery buyer of the million-dollar record as the man who was unrepentant after he raised the price of the aforementioned drug, Daraprim, by 5,000 percent. “It’s a business, we’re supposed to make as much money as possible,”
he explained at a Forbes healthcare conference later.
-- This feed and its contents are the property of The Huffington Post, and use is subject to our
terms. It may be used for personal consumption, but may not be distributed on a website.
More...
04-07-2012, 03:13 AM
Obama Embraces National Security as Campaign Issue
Linear Mode
